Good News for Hormone Replacement Therapy

86

News Flash! You can securely get rid of your hot shine! Estrogen is not so bad. An April 2011 study in the JAMA Journal of the American Medical Association found that estrogen alone reduced the risk of breast cancer and reduced the risk of stroke after stopping the medication.

There is a lot of confusion about hormone replacement therapy. There are a few things you should consider when reviewing a study. Hormone type (synthetic vs. bio-identical), route of administration (oral, transdermal or skin or other), onset age and other treatments. These are just a few thoughts.

Advertisement

The study, cited in the media, was performed on women with hysterectomy using oral oral synthetic estrogen alone without any synthetic progestin. He started using hormones in the 50’s. There were 3 main results:

* The first is that when you stop taking oral synthetic hormone therapy, the increased risk of stroke and the risk of blood clots in the legs and lungs are reduced, as well as the benefits of reducing hip fractures. Note: Oral estrogen alone causes blood clots and increases the risk of stroke. Bio-identical estrogen given through the skin does not increase the risk of stroke or heart disease.

* The second major discovery was the reduced risk of breast cancer. When we followed this for another four years, the risk of breast cancer continued to decrease, thus, throughout the follow-up period, we saw a 23% reduction in the risk of breast cancer. Note: It was an oral, synthetic progestin that was involved in increasing the risk of breast cancer.

• The third discovery is that the risks and benefits of hormone therapy for age-related chronic diseases, heart attacks, colorectal cancer, death and overall chronic diseases are less common in women who take hormone therapy in their 50s. Compared to placebo, but women in their 70s had a higher rate of all these conditions if they were taking estrogen versus placebo alone. Note: The average age of the women studied in the Women’s Health Initiative Study was 63 and most were 10 years after menopause.

So if you are considering hormone replacement therapy, keep in mind the type, route of administration, and age difference when you start taking them. Discuss all your options with a physician who knows bio-identical hormones to determine the most appropriate treatment based on your age, risk factors, and health condition.

Lorraine Maita, MD is a recognized and award-winning doctor and author who is changing people’s lives through prevention and anti-aging medicine. She is a diplomat at the American Academy of Anti-Aging and Regenerative Medicine and Board Certified in Internal Medicine and has over 18 years of experience in Preventive Health and fitness, Internal, professional. and Travel Medicine and Executive Health.

Dr. Maita served as Vice President and Chief Medical Officer at Prudential Financial, Medical Director of the Pfizer Health Leadership Team, and Medical Director of North America for the Johnson & Johnson Global Health Service, and attended St Locks / Roosevelt Hospital, Emergency. The givers were physicians. Department and Executive Health Examiners in New York City. She is a consultant for companies that want to develop or enhance their employee and occupational health and wellness programs and practice privately in Short Hills, NJ.

Healthcare Business Today is a leading online publication that covers the business of healthcare. Our stories are written from those who are entrenched in this field and helping to shape the future of this industry. Healthcare Business Today offers readers access to fresh developments in health, medicine, science, and technology as well as the latest in patient news, with an emphasis on how these developments affect our lives.